06/01/2021 | Press release | Archived content
June 1, 2021
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:TransCode Therapeutics, Inc.
Registration Statement on Form S-1
File No. No. 333-253599
Withdrawal of Prior Acceleration Request
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on May 6, 2021, in which we requested the acceleration of the effective date of the above-captioned Registration Statement, as amended, to 5:00 p.m. Eastern time, on May 10, 2021. We are no longer requesting that the Registration Statement be declared effective at that date and time, and we hereby formally withdraw our prior request for acceleration of the effective date of the above-captioned Registration Statement, as amended.
|Very truly yours,|
|a division of Fordham Financial Management, Inc.|
|By||/s/ Kevin Mangan|
|Name: Kevin Mangan|
|Title: Managing Director, Head of Equity Syndicate|